New medicines save and improve lives every day. This is the foundation and underlying mission of America’s biopharmaceutical research sector.
In recent years, biopharmaceutical innovation has led to accelerated progress in the fight against many diseases. In 2012, the Food and Drug Administration approved 44 new medicines—the largest number in 15 years. Of those, 27 were approved by the Center for Drug Evaluation and Research and seven by the Center for Biologics Evaluation and Research.